Synapse - Works

Results (117469)

Clinical evaluation of Xpert(R) BCR-ABL Ultra, an automated and standardized cartridge-based assay for the quantification of BCR-ABL1

Meeting Abstract

Mauro, M. J.; Press, R. D.; Snyder, D. S.; Huang, Q.; Pinilla-Ibarz, J.; Qin, D. H.; Lockwood, C.; Payton, J. E.; Uy, G. L.; Kalaycio, M. E.; more...
Blood (2015)

Fulltext@MSK | Save

SETD2 heterozygous loss in leukemia leads to chemotherapy resistance through attenuation of the DNA damage response

Meeting Abstract

Mar, B. G.; Kahn, J.; Zon, R. L.; Grauman, P. V.; Boettger, K.; Chu, S. H.; Armstrong, S. A.; Ebert, B. L.
Blood (2015)

Fulltext@MSK | Save

Prospective evaluation of cord blood (CB) & haplo-identical donor availability reveals compromised donor access for both graft types in minorities and high rates of failure to clear haplo donors in adult patients

Meeting Abstract

Kosuri, S.; Wolff, T. F.; Byam, C.; Lauer, E.; Yoo, Y.; Perales, M. A.; Giralt, S. A.; Scaradavou, A.; Ponce, D. M.; Barker, J. N.
Blood (2015)

Fulltext@MSK | Save

Fractionated infusion of hematopoietic progenitor cells does not improve neutrophil recovery or survival in patients undergoing allogeneic hematopoietic cell transplantation for hematologic malignancies

Meeting Abstract

Kosuri, S.; Gyurkocza, B.; Devlin, S.; Maloy, M.; Ciolino, C.; Borrill, T.; Jakubowski, A. A.; Papadopoulos, E. B.; Castro-Malaspina, H. R.; Koehne, G.; more...
Blood (2015)

Fulltext@MSK | Save

High response rate of moxetumomab pasudotox in relapsed/refractory hairy cell leukemia includes eradication of minimal residual disease: Potential importance for outcome

Meeting Abstract

Kreitman, R. J.; Arons, E.; Tallman, M. S.; Tadeusz, R.; Coutre, S.; Wilson, W. H.; Stetler-Stevenson, M.; Yuan, C. M.; Lanasa, M.; FitzGerald, D. J. P.; more...
Blood (2015)

Fulltext@MSK | Save

Incidence and management of proteasome inhibitor-related cardiotoxicity in multiple myeloma patients at Memorial Sloan Kettering Cancer Center

Meeting Abstract

Land, J.; Afifi, S.; Adel, N. G.; Devlin, S.; Arora, A.; Lendvai, N.; Landgren, O.
Blood (2015)

Fulltext@MSK | Save

High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse risk features and poor outcome in pediatric acute myeloid leukemia: A report from the Children's Oncology Group

Meeting Abstract

Laszlo, G. S.; Alonzo, T. A.; Gudgeon, C. J.; Harrington, K. H.; Kentsis, A.; Gerbing, R. B.; Wang, Y. C.; Ries, R. E.; Raimondi, S. C.; Hirsch, B. A.; more...
Blood (2015)

Fulltext@MSK | Save

Ibrutinib alone and in combination with dexamethasone and carfilzomib significantly inhibits cell proliferation in primary mediastinal B-cell lymphoma (PMBL): Ibrutinib may be a future targeted agent in combination therapy in patients with PMBL

Meeting Abstract

Lee, S.; Yin, C.; Ayello, J.; Morris, E.; Harrison, L.; van de Ven, C.; Barth, M. J.; Miles, R. R.; Galardy, P. J.; Goldman, S.; more...
Blood (2015)

Fulltext@MSK | Save

Ibrutinib significantly prolonged survival in a human Burkitt lymphoma (BL) xenograft NSG mouse model: Ibrutinib may be a potential adjuvant agent in the treatment of BL

Meeting Abstract

Lee, S.; Yin, C.; Ayello, J.; Morris, E.; O'Connell, T.; Harrison, L.; van de Ven, C.; Barth, M. J.; Miles, R. R.; Galardy, P. J.; more...
Blood (2015)

Fulltext@MSK | Save

Burden of pneumococcal disease in cancer patients: A 20 year single center study at Memorial Sloan-Kettering Cancer Center

Meeting Abstract

Lee, Y. J.; Huang, Y. T. H.; Kim, S. J.; Kerpelev, M.; Gonzalez, V.; Papanicolaou, G. A.; Kaltsas, A.
Blood (2015)

Fulltext@MSK | Save